Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation. - Wikidata - awgldk - TriplyDB

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.

http://www.wikidata.org/entity/Q44304931

about

Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice Disordered follicle development Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications Comparability of antimüllerian hormone levels among commercially available immunoassays The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women FSH and its second messenger cAMP stimulate the transcription of human anti-Müllerian hormone in cultured granulosa cells.The hormonal composition of follicular fluid and its implications for ovarian cancer pathogenesis Maternal antimullerian hormone levels do not predict fetal aneuploidy.Anti-mullerian hormone and cumulative pregnancy outcome in in-vitro fertilization.Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis.Prediction of reproductive outcomes according to different serum anti-Müllerian hormone levels in females undergoing intracystoplasmic sperm injection The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women Single nucleotide polymorphisms in the Anti-Müllerian hormone (AMH Ile(49)Ser) and Anti-Müllerian hormone type II receptor (AMHRII -482 A>G) as genetic markers in assisted reproduction technology.Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome.Effects of GnRH agonists on the expression of developmental follicular anti-mullerian hormone in varying follicular stages in cyclic mice in vivo.Correlation of serum Anti-Müllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients.The effect of abdominal radical trachelectomy on ovarian reserve: serial changes in serum anti-müllerian hormone levels Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments.Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth.Maternal antimullerian hormone as a predictor of fetal aneuploidy occurring in an early pregnancy loss.Anti-Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration.Serum anti-Müllerian hormone and inhibin B levels at ovulation triggering day can predict the number of immature oocytes retrieved in in vitro fertilization cycles.Association between serum anti-Müllerian hormone level and ovarian response to mild stimulation in normoovulatory women and anovulatory women with polycystic ovary syndrome The relationship between Anti-Müllerian hormone and other reproductive parameters in normal women and in women with polycystic ovary syndrome Why Healthcare Providers Should Focus on the Fertility of AYA Cancer Survivors: It's Not Too Late!Anti mullerian hormone: a potential marker for recruited non growing follicle of ovarian pool in women with polycystic ovarian syndrome.Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).The effect of ovarian puncture on the endocrine profile of PCOS patients who undergo IVM The correlation of the antral follicle count and Serum anti-mullerian hormone.Assessment of ovarian reserve and Doppler characteristics in patients with multiple sclerosis using immunomodulating drugs.Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction.Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology.Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes.

P2860

Q26829747-CDFACDE5-D2B4-42DE-A671-A1A43429CBC7 Q26851230-090E7BC6-3320-4C79-9D65-81E6B5CF5EDB Q28239980-D708B09E-040F-4D52-B1A4-0F6D2913295F Q28388149-AA5BD81D-D4A0-42DC-A543-F12C9EBC08EE Q28392230-556ABD2B-21EF-4B0B-B334-EF75C1300294 Q30439646-43260812-6B3B-4535-9F3D-A91D10485650 Q33636964-69745FB7-57DE-46E1-8139-24803C4C3567 Q33926671-C7CC0572-281F-4B70-A2EB-2179DBBE4D11 Q34070204-83CE7F5B-20DE-4C42-B021-F679E68E0839 Q34138075-207A901B-DB53-4512-B4E1-76CDBAECC082 Q34226336-E22C7386-6B79-4D1E-8E45-3317714A6408 Q34700094-2157D8A1-A30B-4C16-8C60-09C112F0A903 Q34999705-5D7D0600-4938-4210-B94F-0A8A43403DCA Q35166382-426DB265-5063-41B7-BC84-D37F5A1EFD45 Q35186943-C7CF79B5-814F-4B87-B986-74B07E4D2CE8 Q35898934-813EA828-C241-407E-AD57-6E29705DC218 Q35919719-2BBA51D0-349C-49F2-8AF3-AB229344E6EE Q35946575-83F1A996-5F73-4B02-B8DA-3DD7B2E1A1BA Q35966464-EEA80FDF-DD8E-4A4B-A906-A3515B0A1716 Q35966481-0C82E77A-A515-4325-B070-75952B58E9EF Q35976287-30A469C9-8720-48BA-AEDE-36189B34E0E7 Q36082015-06FDC100-43C9-4518-ADCF-988A65E3C6A8 Q36182579-82349445-3B76-466A-8C19-FEE7061EE743 Q36328655-6A7CDC2F-8EFD-42C5-B5CC-5941502D0CC4 Q36483196-53344255-778E-4D4C-A6FF-F67E793D7DD6 Q36484614-78F92F4E-3A72-4F8F-83E8-79258CBF973F Q36853993-75AFA68E-FC4A-46E6-9397-55F61ADFDA37 Q37022417-5D6EDDBF-B1F2-4DB9-B983-03AC900BA166 Q37050664-B9E18969-7814-461C-A680-4E3F70277FDF Q37218794-CE102FCC-BB5D-4A06-8572-018FA703565B Q37258799-D8AB5298-A4AD-4873-8FC1-A8E09EE2AED9 Q37606149-F5F84634-7AE3-43AC-B95C-0C9C1D7B0698 Q37607260-0E8BAE90-27F6-4124-B95E-C08297A8E3C7 Q37611192-4A23D0FB-9BCC-46F4-9F07-6BE694DF8AEF Q37611215-318C9040-0391-4BDB-81E6-03055AEA58E4 Q38482450-5EC5B1C9-5151-4E91-AAC2-DC6B05DB32BC Q38938581-B91562CF-AC4C-4046-91F5-9D2A469E88D7 Q39888178-3CAA1B4C-BF5B-49BB-8640-B0166A4993DB Q40394248-EFE5A7F1-F099-4DB5-837B-64A1B5171893 Q42491370-B8834C49-B35F-4478-BE17-FB8DA827D614

P2860

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.

http://www.wikidata.org/entity/Q44304931

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.

@en

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.

@nl

type

label

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.

@en

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.

@nl

prefLabel

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.

@en

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.

@nl

P1433

Q44304931-9A72066F-40DC-4B5A-AB0F-DCACA9E5D306

P1476

Q44304931-C199C1B6-4417-4A5F-A239-110C4ADC91CD

P2093

Q44304931-3DE3657B-E634-455E-B747-128F9B731E23

Q44304931-4E3902AA-FF76-4524-9D21-A3BE4F9276F0

Q44304931-684062EE-23D2-4AF8-BB1B-21CBB8377A22

Q44304931-A2CF6F50-1C31-47B4-B7C4-E0B313FECD2F

Q44304931-B74E87D9-D826-4836-A6A8-D69BFEA217D4

Q44304931-C7206C90-7FC3-46F8-A78B-7DA3A387DF52

P304

Q44304931-21E0F42B-5034-4C87-AD2E-A2B3315C4784

P31

Q44304931-823A677E-931A-4CD1-8A1B-7451FB7FF767

P356

Q44304931-67CB6D3A-A3A0-4FD5-BDBE-727A29DB5A4E

P407

Q44304931-B674EEBB-5426-4840-B19B-BAB31531D0EC

P433

Q44304931-FF94C3F5-22CF-41A8-9FAB-DDAB68AE5BFA

P478

Q44304931-C202E7D0-9E9F-4740-B240-E9B824EC8B29

P577

Q44304931-8618ACA7-B31B-4EF4-8A50-E9F3BAA9E97D

P5875

Q44304931-E3F9B836-C1EA-476A-A2A1-1307D6CD409F

P698

Q44304931-916D8BC3-7E0C-46D2-A1E3-993E1B9716EC

P356

P1433

Human Reproduction

P1476

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation.

@en

P2093

Claudia Righini

http://www.w3.org/2001/XMLSchema#string

Joëlle Taieb

http://www.w3.org/2001/XMLSchema#string

Luca Maria Schonäuer

http://www.w3.org/2001/XMLSchema#string

Nelly Frydman

http://www.w3.org/2001/XMLSchema#string

Renato Fanchin

http://www.w3.org/2001/XMLSchema#string

René Frydman

http://www.w3.org/2001/XMLSchema#string

P304

328-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMREP/DEG043

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10914537

http://www.w3.org/2001/XMLSchema#string

P698

12571169

http://www.w3.org/2001/XMLSchema#string